Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy

Biomaterials

Volumn 32, Issue 21, 2011, Pages 4976-4986

  Deng, Ziwei ^a   Zhen, Zipeng ^b   Hu, Xiaoxi ^a   Wu, Shuilin ^a,c   Xu, Zushun ^a,c   Chu, Paul K ^c  

^a HUBEI UNIVERSITY   (China)

^b LINYI UNIVERSITY   (China)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Breast cancer therapy; Chitosan; Drug release; Hollow nanospheres; PH responsive; Silica

Indexed keywords

CELLS; CHITOSAN; CONTROLLED DRUG DELIVERY; CROSSLINKING; DISEASES; NANOSPHERES; ONCOLOGY; PH SENSORS; SILICA;

BREAST CANCER; CATIONIC POLYSACCHARIDE; CROSSLINKING REACTION; DRUG RELEASE; HOLLOW NANOSPHERES; MCF-7 BREAST CANCER CELLS; PH-RESPONSIVE; THERAPEUTIC EFFICACY;

TARGETED DRUG DELIVERY;

(3 GLYCIDYLOXYPROPYL)TRIMETHOXYSILANE; CHITOSAN; DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOCARRIER; NANOSPHERE; SILANE DERIVATIVE; SILICON DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER THERAPY; CELL KILLING; CELL STRAIN MCF 7; CONJUGATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 79955764203     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.050     Document Type: Article

References (49)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
2. Jones D. Cancer nanotechnology: small, but heading for the big time. Nat Rev Drug Discov 2007, 6:174-175.
3. Peer D., Karp J.M., Hong S., FaroKhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
4. West J.L., Halas N.J. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annu Rev Biomed Eng 2003, 5:285-292.
5. Lee J.H., Huh Y.M., Jun Y., Seo J., Jang J., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
6. Quintana A., Raczka E., Piehler L., Lee I., Myc A., Majoros I., et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 2002, 19:1310-1316.
7. El-Sayed I.H., Huang X.H., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 2005, 5:829-834.
8. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
9. Huang X.H., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128:2115-2120.
10. Mal N.K., Fujiwara M., Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 2003, 421:350-353.
11. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W.K., Nie S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
12. Yavuz M.S., Cheng Y., Chen J., Cobley C.M., Zhang Q., Rycenga M., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009, 8:935-939.
13. Zhu Y.F., Shi J.L., Shen W.H., Dong X.P., Feng J.W., Ruan M.L., et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Ed 2005, 44:5083-5087.
14. Jiang X.M., Ward T.L., Cheng Y.S., Liu J.W., Brinker C.J. Aerosol fabrication of hollow mesoporous silica nanoparticles and encapsulation of L-methionine as a candidate drug cargo. Chem Commun 2010, 46:3019-3021.
15. Zhu Y.F., Shi J.L., Shen W.H., Chen H.R., Dong X.P., Ruan M.L. Preparation of novel hollow mesoporous silica spheres and their sustained-release property. Nanotechnology 2005, 16:2633-2638.
16. Botterhuis N.E., Sun Q.Y., Magusin P., van Santen R.A., Sommerdijk N. Hollow silica spheres with an ordered pore structure and their application in controlled release studies. Chem Eur J 2006, 12:1448-1456.
17. Yang J., Lee J., Kang J., Lee K., Suh J.S., Yoon H.G., et al. Hollow silica nanocontainers as drug delivery vehicles. Langmuir 2008, 24:3417-3421.
18. Yan E.Y., Ding Y., Chen C.J., Li R.T., Hu Y., Jiang X.Q. Polymer/silica hybrid hollow nanospheres with pH-sensitive drug release in physiological and intracellular environments. Chem Commun 2009, 2718-2720.
19. Lay C.L., Liu H.Q., Wu D.C., Liu Y. Poly(ethylene glycol)-graft-hollow silica vesicles for drug delivery. Chem Eur J 2010, 16:3001-3004.
20. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescenceimaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
21. Zhu J., Tang J.W., Zhao L.Z., Zhou X.F., Wang Y.H., Yu C.Z. Ultrasmall, well-dispersed, hollow siliceous spheres with enhanced endocytosis properties. Small 2010, 6:276-282.
22. Lu Y., Fan H., Stump A., Ward T.L., Rieker T., Brinker C.J. Aerosol-assisted self-assembly of mesostructured spherical nanoparticles. Nature 1999, 398:223-226.
23. Nagao D., van Kats C.M., Hayasaka K., Sugimoto M., Konno M., Imhof A., et al. Synthesis of hollow asymmetrical silica dumbbells with a movable inner core. Langmuir 2010, 26:5208-5212.
24. Tissot I., Reymond J.P., Lefebvre F., Bourgeat-Lami E. SiOH-functionalized polystyrene latexes. A step toward the synthesis of hollow silica nanoparticles. Chem Mater 2002, 14:1325-1331.
25. Lu Y., McLellan J., Xia Y.N. Synthesis and crystallization of hybrid spherical colloids composed of polystyrene cores and silica shells. Langmuir 2004, 20:3464-3470.
26. Caruso F., Caruso R.A., Mohwald H. Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science 1998, 282:1111-1114.
27. Deng Z.W., Chen M., Zhou S.X., You B., Wu L.M. A novel method for the fabrication of monodisperse hollow silica spheres. Langmuir 2006, 22:6403-6407.
28. Shi J., Votruba A.R., Farokhzad O.C., Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
29. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
30. Bhattarai N., Gunn J., Zhang M.Q. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010, 62:83-99.
31. Schuetz Y.B., Gurny R., Jordan O. A novel thermoresponsive hydrogel based on chitosan. Eur J Pharm Biopharm 2008, 68:19-25.
32. 2 as a pH responsive nano-valve for triggered release of insulin. Adv Funct Mater 2009, 19:733-741.
33. Yang Q., Wang S.H., Fan P.W., Wang L.F., Di Y., Lin K.F., et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mater 2005, 17:5999-6003.
34. Thistlethwaite A.J., Leeper D.B., Moylan Iii D.J., Nerlinger R.E. pH distribution in human tumors. Int J Radiat Oncol Biol Phys 1985, 11:1647-1652.
35. Kallinowski F., Vaupel P. pH distributions in spontaneous and isotransplanted rat tumours. Br J Cancer 1988, 58:314-321.
36. Liu Y.L., Su Y.H., Lai J.Y. In situ crosslinking of chitosan and formation of chitosan-silica hybrid membranes with using gamma-glycidoxypropyltrimethoxysilane as a crosslinking agent. Polymer 2004, 45:6831-6837.
37. 2 hollow mesoporous spheres for targeted anticancer drug delivery. J Phys Chem C 2010, 114:16382-16388.
38. Brouckaert P.G.G., Leroux-Roels G.G., Guisez Y., Tavernier J., Fiers W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma. Int J Cancer 1986, 38:763-769.
39. Balkwill F.R., Lee A., Aldam G., Moodie E., Thomas J.A., Tavernier J., et al. Human- tumor xenografts treated with recombinant human-tumor necrosis factor alone or in combination with interferons. Cancer Res 1986, 46:3990-3993.
40. Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A., Shepard H.M. Recombinant human-tumor necrosis factor-alpha:effects on proliferation of normal and transformed cells in vitro. Science 1985, 230:943-945.
41. Mansur H.S., Oréfice R.L., Vasconcelos W.L., Lobato Z.P., Machado L.J.C. Biomaterial with chemically engineered surface for protein immobilization. J Mater Sci Mater Med 2005, 16:333-340.
42. Cai W.Y., Gentle I.R., Lu G.Q., Zhu J.J., Yu A.M. Mesoporous silica templated biolabels with releasable fluorophores for immunnoassays. Anal Chem 2008, 80:5401-5406.
43. Song S.W., Hidajat K., Kawi S. pH-controllable drug release using hydrogel encapsulated mesoporous silica. Chem Commun 2007, 4396-4398.
44. Hueber A.O. Role of membrane microdomain rafts in TNFR-mediated signal transduction. Cell Death Differ 2003, 10:7-9.
45. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009, 9:361-371.
46. Akita H., Harashima H. Advances in non-viral gene delivery: using multifunctional envelope-type nano-device. Expert Opin Drug Delivery 2008, 5:847-859.
47. 4 nanoparticles for targeted delivery and controlled release of cisplatin. J Am Chem Soc 2009, 131:10637-10644.
48. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010, 9:615-627.
49. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 2006, 6:583-592.